The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma

导出

摘要 The Society for Immunotherapy of Cancer(SITC)published clinical practice guideline on immunotherapy for hepatocellular carcinoma(HCC)(1).Many clinical practice guidelines for HCC have been published by academic societies worldwide(2),but the SITC guideline is the first to focus exclusively on immunotherapy.

作者 Masatoshi Kudo

机构地区 Department of Gastroenterology and Hepatology

出处《Hepatobiliary Surgery and Nutrition》 SCIE 2023年第2期256-260,共5页 肝胆外科与营养（英文）

关键词 Hepatocellular carcinoma(HCC) IMMUNOTHERAPY combination immunotherapy immunotherapy combined with locoregional therapy

分类号 R735.7 [医药卫生—肿瘤]

引文网络
相关文献

1Zhongkai Wang,Brian K.P.Goh.Editorial comment on: surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: comparison to a benchmark procedure[J].Hepatobiliary Surgery and Nutrition,2021,10(4):570-572.
2Jian Xue,Hongbo Ni,Fan Wang,Ke Xu,Meng Niu.Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy[J].Journal of Interventional Medicine,2021,4(3):105-113. 被引量：32
3Mina S Makary,Stuart Ramsell,Eric Miller,Eliza W Beal,Joshua D Dowell.Hepatocellular carcinoma locoregional therapies:Outcomes and future horizons[J].World Journal of Gastroenterology,2021,27(43):7462-7479. 被引量：5
4Anh Duy Pham,Karl Vaz,Zaid S Ardalan,Marie Sinclair,Ross Apostolov,Sarah Gardner,Ammar Majeed,Gauri Mishra,Ning Mao Kam,Kurvi Patwala,Numan Kutaiba,Niranjan Arachchi,Sally Bell,Anouk T Dev,John S Lubel,Amanda J Nicoll,Siddharth Sood,William Kemp,Stuart K Roberts,Michael Fink,Adam G Testro,Peter W Angus,Paul J Gow.Clinical outcomes of patients with two small hepatocellular carcinomas[J].World Journal of Hepatology,2021,13(10):1439-1449.
5Nan Yang,Wei Zhao,Wen-An Qi,Chen Yao,Chong-Ya Dong,Zhen-Guo Zhai,Tong Chen,En-Mei Liu,Guo-Bao Li,You-Lin Long,Xin-Yi Wang,Zi-Jun Wang,Ruo-Bing Lei,Qi Zhou,Yao-Long Chen,Liang Du,on behalf of TERM working group.Publishing clinical prActice GuidelinEs(PAGE):Recommendations from editors and reviewers[J].Chinese Journal of Traumatology,2022,25(6):312-316. 被引量：1
6Ciro Celsa,Lucia Cerrito,Leonardo Stella,Roberta Ciccia,Giuseppe Cabibbo,Francesca Romana Ponziani.Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice[J].Hepatobiliary Surgery and Nutrition,2023,12(2):252-255. 被引量：1
7Jun Chen,Tian Shen,Jianhui Li,Sunbin Ling,Zhe Yang,Guoying Wang,Liying Sun,Zhaoxu Yang,Li Zhuang,Jie Gao,Wenyuan Guo,Jie Li,Shengjun Xu,Qiang Wei,Shusen Zheng,Xiao Xu.Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China(2021 edition)[J].Chinese Medical Journal,2022,135(24):2911-2913. 被引量：13
8Shalom Z Frager,Weston Cooper,Yvonne Saenger,Jonathan M Schwartz.Treatment of recurrent hepatocellular carcinoma following liver resection,ablation or liver transplantation[J].World Journal of Meta-Analysis,2023,11(2):47-54.
9Woo Jin Choi,Gonzalo Sapisochin.Pushing the limits for the surgical treatment of intrahepatic cholangiocarcinoma[J].Hepatobiliary Surgery and Nutrition,2023,12(1):99-104.
10Cody R Criss,Mina S Makary.Salvage locoregional therapies for recurrent hepatocellular carcinoma[J].World Journal of Gastroenterology,2023,29(3):413-424. 被引量：1

Hepatobiliary Surgery and Nutrition

2023年第2期

浏览历史

内容加载中请稍等...

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma

相关作者

相关机构

相关主题

浏览历史